Search results for "Vaccinations"
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Flu vaccination is rarely associated with subdeltoid bursitis, study finds
Clinicians could benefit from an injection technique “tune-up” in needle placement and needle length, an editorial suggested.
https://immattersacp.org/weekly/archives/2020/06/23/6.htm
23 Jun 2020
Experts cover common COVID-19 challenges
A recent ACP/Annals of Internal Medicine forum on COVID-19 considered the timing of vaccination, outpatient treatment, and pre-exposure prophylaxis.
https://immattersacp.org/archives/2022/10/experts-cover-common-covid-19-challenges.htm
1 Oct 2022
Latest on COVID-19 and bamlanivimab, vaccines, long-term effects
Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021
New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’
The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021
Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021